UBS Group lowered shares of SSAB AB (publ) (OTCMKTS:SSAAY – Get Rating) from a buy rating to a neutral rating in a report released on Tuesday, The Fly reports.
SSAAY has been the subject of a number of other reports. Morgan Stanley cut SSAB AB (publ) from an overweight rating to an equal weight rating in a research note on Friday, February 3rd. Deutsche Bank Aktiengesellschaft increased their price target on SSAB AB (publ) from SEK 63 to SEK 68 and gave the company a hold rating in a research note on Wednesday, January 18th. JPMorgan Chase & Co. raised their price objective on SSAB AB (publ) from SEK 49 to SEK 50 and gave the stock an underweight rating in a research note on Thursday, January 19th. Finally, Danske cut SSAB AB (publ) from a hold rating to a sell rating in a research note on Thursday, December 22nd. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of Hold and a consensus target price of $69.25.
SSAB AB (publ) Price Performance
Shares of SSAAY stock opened at $3.62 on Tuesday. SSAB AB has a 1-year low of $2.03 and a 1-year high of $4.03. The stock’s 50-day moving average is $3.39 and its 200 day moving average is $2.85. The company has a market cap of $7.46 billion, a P/E ratio of -8.62 and a beta of 1.31. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.53 and a quick ratio of 1.29.
About SSAB AB (publ)
SSAB AB engages in the production of steel and construction solutions. It operates through the following segments: SSAB Special Steels, SSAB Europe, SSAB Americas, Tibnor and Ruukki Construction. The SSAB Special Steels segment markets and sells quenched, tempered, and hot rolled steels. The SSAB Europe segment focuses on strip, plate, and tubular products.
- Get a free copy of the StockNews.com research report on SSAB AB (publ) (SSAAY)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for SSAB AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SSAB AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.